The similar strategy was used to elucidate the influence of PD-1 or PD-L1 involved treatment lines on the risk of developing rash (Figures 2(b), 3(b), 4(b), 4(f), 5(c), and 5(e)). This evidence concerns the gene PDCD1 and Skin rash.